Cargando…
When and how do patients with cardiac amyloidosis die?
BACKGROUND: Cardiac amyloidosis (CA) is an underappreciated cause of morbidity and mortality. Light-chain (AL) and transthyretin (ATTR) amyloidosis have different disease trajectories. No data are available on subtype-specific modes of death (MOD) in patients with CA. METHODS AND RESULTS: We retrosp...
Autores principales: | Escher, F., Senoner, M., Doerler, J., Zaruba, M. M., Messner, M., Mussner-Seeber, C., Ebert, M., Ensinger, C., Mair, A., Kroiss, A., Ulmer, H., Schneiderbauer-Porod, S., Ebner, C., Poelzl, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6952329/ https://www.ncbi.nlm.nih.gov/pubmed/31134330 http://dx.doi.org/10.1007/s00392-019-01490-2 |
Ejemplares similares
-
Heart failure from ATTRwt amyloid cardiomyopathy is associated with poor prognosis
por: Kocher, Florian, et al.
Publicado: (2020) -
Klotho is upregulated in human cardiomyopathy independently of circulating Klotho levels
por: Poelzl, G., et al.
Publicado: (2018) -
Amyloid myopathy: expanding the clinical spectrum of transthyretin amyloidosis—case report and literature review
por: Ungericht, Maria, et al.
Publicado: (2022) -
Eosinophilic myocarditis complicated by permanent atrioventricular nodal block: a case report
por: Messner, Moritz, et al.
Publicado: (2022) -
Pseudoxanthoma elasticum: Die Lotsenfunktion des Dermatologen
por: Burghaus, Jana, et al.
Publicado: (2022)